References
1. HAPO Study Cooperative Research Group. Hyperglycemia and adverse
pregnancy outcomes. New England Journal of Medicine.
2008;358(19):1991-2002.
2. Villamor E, Cnattingius S. Interpregnancy weight change and risk of
adverse pregnancy outcomes: a population-based study. The Lancet.
2006;368(9542):1164-70.
3. American Diabetes Association. 2. Classification and diagnosis of
diabetes. Diabetes care. 2015;38(Supplement 1):S8-S16.
4. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al.
Global, regional, and national prevalence of overweight and obesity in
children and adults during 1980–2013: a systematic analysis for the
Global Burden of Disease Study 2013. The lancet. 2014;384(9945):766-81.
5. Rogozińska E, Marlin N, Jackson L, Bogaerts A, Rayanagoudar G,
Ruifrok AE, et al. Effects of antenatal diet and physical activity on
maternal and fetal outcomes: individual patient data meta-analysis and
health economic evaluation. Health Technol Assess. 2017;21(41):1-+.
6. Barrett HL, Nitert MD, McIntyre HD, Callaway LK. Normalizing
metabolism in diabetic pregnancy: is it time to target lipids? Diabetes
care. 2014;37(5):1484-93.
7. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity
and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol
Regul Integr Comp Physiol. 2010;299(3):R711-22.
8. Scholtens DM, Bain JR, Reisetter AC, Muehlbauer MJ, Nodzenski M,
Stevens RD, et al. Metabolic networks and metabolites underlie
associations between maternal glucose during pregnancy and newborn size
at birth. Diabetes. 2016:db151748.
9. Zawiejska A, Wender-Ozegowska E, Brazert J, Sodowski K. Components of
metabolic syndrome and their impact on fetal growth in women with
gestational diabetes mellitus. J Physiol Pharmacol. 2008;59(Suppl
4):5-18.
10. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter
K, et al. Maternal lipids as strong determinants of fetal environment
and growth in pregnancies with gestational diabetes mellitus. Diabetes
Care. 2008;31(9):1858-63.
11. Pittavino M, Lewis F, Furrer R. abn: an R package for modelling
multivariate data using additive Bayesian networks. The Comprehensive R
Archive Network (CRAN), 1–37. 2016.
12. Koivisto M, Sood K. Exact Bayesian structure discovery in Bayesian
networks. Journal of Machine Learning Research. 2004;5(May):549-73.
13. Qiu X, Lu J-H, He J-R, Lam K-bH, Shen S-Y, Guo Y, et al. The Born in
Guangzhou Cohort Study (BIGCS). European Journal of Epidemiology.
2017;32(4):337-46.
14. International Association of Diabetes: Pregnancy Study Groups
Consensus Panel. International association of diabetes and pregnancy
study groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes care. 2010;33(3):676-82.
15. Chen C, Lu F. The guidelines for prevention and control of
overweight and obesity in Chinese adults. Biomedical and environmental
sciences: BES. 2004;17:1-36.
16. Villar J, Papageorghiou AT, Pang R, Ohuma EO, Ismail LC, Barros FC,
et al. The likeness of fetal growth and newborn size across non-isolated
populations in the INTERGROWTH-21 st Project: the Fetal Growth
Longitudinal Study and Newborn Cross-Sectional Study. Lancet Diabetes
Endocrinol. 2014;2(10):781-92.
17. Edison RJ, Berg K, Remaley A, Kelley R, Rotimi C, Stevenson RE, et
al. Adverse birth outcome among mothers with low serum cholesterol.
Pediatrics. 2007;120(4):723-33.
18. Sandler V, Reisetter AC, Bain JR, Muehlbauer MJ, Nodzenski M,
Stevens RD, et al. Associations of maternal BMI and insulin resistance
with the maternal metabolome and newborn outcomes. Diabetologia.
2017;60(3):518-30. doi: 10.1007/s00125-016-4182-2. Epub 2016 Dec 16.
19. Kadakia R, Nodzenski M, Talbot O, Kuang A, Bain JR, Muehlbauer MJ,
et al. Maternal metabolites during pregnancy are associated with newborn
outcomes and hyperinsulinaemia across ancestries. Diabetologia.
2018;27(10):018-4781.
20. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of
progression to type 2 diabetes: a global perspective. Current diabetes
reports. 2016;16(1):7.
21. Mingrone G, Manco M, Mora MEV, Guidone C, Iaconelli A, Gniuli D, et
al. Influence of maternal obesity on insulin sensitivity and secretion
in offspring. Diabetes care. 2008;31(9):1872-6.
22. He XJ, Qin FY, Hu CL, Zhu M, Tian CQ, Li L. Is gestational diabetes
mellitus an independent risk factor for macrosomia: a meta-analysis?
Archives of Gynecology and Obstetrics. 2015;291(4):729-35.
23. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin
resistance. Physiological reviews. 2018;98(4):2133-223.
24. Lawlor DA, West J, Fairley L, Nelson SM, Bhopal RS, Tuffnell D, et
al. Pregnancy glycaemia and cord-blood levels of insulin and leptin in
Pakistani and white British mother–offspring pairs: findings from a
prospective pregnancy cohort. Diabetologia. 2014;57(12):2492-500.
25. Varlamov O, Somwar R, Cornea A, Kievit P, Grove KL, Roberts Jr CTJ.
Single-cell analysis of insulin-regulated fatty acid uptake in
adipocytes. American Journal of Physiology-Endocrinology & Metabolism.
2010;299(3):E486-E96.
26. Wang J, Moore D, Subramanian A, Cheng K, Toulis K, Qiu X, et al.
Gestational dyslipidaemia and adverse birthweight outcomes: a systematic
review and meta‐analysis. Obes Rev. 2018.
27. Tyrrell J, Richmond RC, Palmer TM, Feenstra B, Rangarajan J,
Metrustry S, et al. Genetic evidence for causal relationships between
maternal obesity-related traits and birth weight. Jama.
2016;315(11):1129-40.
28. NICE. Weight management before, during and after pregnancy. 2010.
29. Rasmussen KM, Yaktine AL. Weight gain during pregnancy: reexamining
the guidelines: National Academies Press; 2010.
30. Royal College of Obstetricians and Gynaecologists. Care of women
with obesity in pregnancy (Green-top Guideline No. 72). 2018 Nov 22.
31. Bannon AL, Waring ME, Leung K, Masiero JV, Stone JM, Scannell EC, et
al. Comparison of self-reported and measured pre-pregnancy weight:
implications for gestational weight gain counseling. Maternal and child
health journal. 2017;21(7):1469-78.